In male rats. Comparison of the metabolic profile of NNEI to its indazole analogue MN-18 exposed marked dissimilarities in pharmacokinetic parameters and metabolic pathways. Especially, compound 187 exerted important human body bodyweight reduction in food plan-induced obese F344 rats and was expected for being a novel antiobesity agent depending on https://hemalchem.com/product-category/indazole-based/